| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tomography, X-Ray Computed | 42 | 2023 | 770 | 6.150 |
Why?
|
| Lumbar Vertebrae | 28 | 2023 | 487 | 5.960 |
Why?
|
| Imaging, Three-Dimensional | 36 | 2023 | 222 | 4.770 |
Why?
|
| Low Back Pain | 11 | 2019 | 139 | 3.920 |
Why?
|
| Femur | 18 | 2023 | 396 | 3.480 |
Why?
|
| Intervertebral Disc | 11 | 2021 | 212 | 3.160 |
Why?
|
| Intervertebral Disc Degeneration | 9 | 2021 | 116 | 2.240 |
Why?
|
| Zygapophyseal Joint | 7 | 2019 | 44 | 2.220 |
Why?
|
| Hip Dislocation | 3 | 2020 | 65 | 2.070 |
Why?
|
| Acetabulum | 4 | 2020 | 208 | 2.010 |
Why?
|
| Range of Motion, Articular | 21 | 2023 | 699 | 1.850 |
Why?
|
| Bone Density | 5 | 2021 | 134 | 1.590 |
Why?
|
| Middle Aged | 41 | 2021 | 9823 | 1.470 |
Why?
|
| Adult | 41 | 2021 | 8601 | 1.420 |
Why?
|
| Male | 59 | 2023 | 15621 | 1.410 |
Why?
|
| Young Adult | 19 | 2021 | 1932 | 1.300 |
Why?
|
| Humans | 78 | 2023 | 29337 | 1.280 |
Why?
|
| Tibia | 11 | 2020 | 259 | 1.280 |
Why?
|
| Female | 46 | 2023 | 16197 | 1.260 |
Why?
|
| Lumbosacral Region | 6 | 2021 | 69 | 1.230 |
Why?
|
| Biomechanical Phenomena | 30 | 2023 | 668 | 1.210 |
Why?
|
| Femur Head | 4 | 2020 | 66 | 1.130 |
Why?
|
| Knee Joint | 13 | 2023 | 797 | 1.080 |
Why?
|
| Anterior Cruciate Ligament Reconstruction | 2 | 2018 | 235 | 1.000 |
Why?
|
| Baseball | 2 | 2022 | 105 | 0.930 |
Why?
|
| Surgery, Computer-Assisted | 2 | 2023 | 60 | 0.920 |
Why?
|
| Cadaver | 14 | 2020 | 359 | 0.870 |
Why?
|
| Magnetic Resonance Imaging | 11 | 2021 | 1221 | 0.870 |
Why?
|
| Bone Transplantation | 11 | 2021 | 224 | 0.830 |
Why?
|
| Spinal Fractures | 1 | 2021 | 60 | 0.800 |
Why?
|
| Spondylosis | 3 | 2017 | 32 | 0.800 |
Why?
|
| Cervical Vertebrae | 8 | 2021 | 349 | 0.770 |
Why?
|
| Spine | 3 | 2018 | 121 | 0.740 |
Why?
|
| Spinal Fusion | 9 | 2023 | 516 | 0.730 |
Why?
|
| Anterior Cruciate Ligament | 2 | 2018 | 270 | 0.690 |
Why?
|
| Prosthesis Implantation | 2 | 2010 | 33 | 0.660 |
Why?
|
| Image Processing, Computer-Assisted | 6 | 2021 | 219 | 0.660 |
Why?
|
| X-Ray Microtomography | 6 | 2021 | 72 | 0.650 |
Why?
|
| Shoulder Joint | 2 | 2022 | 572 | 0.640 |
Why?
|
| Osteoarthritis, Knee | 1 | 2023 | 381 | 0.640 |
Why?
|
| Weight-Bearing | 10 | 2016 | 164 | 0.640 |
Why?
|
| Nucleus Pulposus | 1 | 2017 | 12 | 0.630 |
Why?
|
| Ligaments, Articular | 1 | 2018 | 104 | 0.620 |
Why?
|
| Flatfoot | 5 | 2016 | 5 | 0.600 |
Why?
|
| Knee Injuries | 2 | 2020 | 223 | 0.580 |
Why?
|
| Cartilage, Articular | 5 | 2021 | 524 | 0.580 |
Why?
|
| Bone Morphogenetic Proteins | 6 | 2007 | 102 | 0.570 |
Why?
|
| Arthroplasty, Replacement, Knee | 2 | 2023 | 696 | 0.570 |
Why?
|
| Manipulation, Spinal | 1 | 2016 | 5 | 0.570 |
Why?
|
| Torsion, Mechanical | 1 | 2016 | 4 | 0.570 |
Why?
|
| Transforming Growth Factor beta | 6 | 2007 | 123 | 0.570 |
Why?
|
| Proteoglycans | 3 | 2017 | 337 | 0.570 |
Why?
|
| Aged | 22 | 2023 | 9448 | 0.550 |
Why?
|
| Ligamentum Flavum | 1 | 2015 | 6 | 0.540 |
Why?
|
| Diskectomy | 2 | 2021 | 195 | 0.490 |
Why?
|
| Animals | 28 | 2021 | 4552 | 0.480 |
Why?
|
| Computer Simulation | 6 | 2021 | 218 | 0.480 |
Why?
|
| Femoracetabular Impingement | 4 | 2021 | 168 | 0.470 |
Why?
|
| Joint Instability | 6 | 2021 | 387 | 0.460 |
Why?
|
| Aortic Aneurysm | 1 | 2012 | 10 | 0.430 |
Why?
|
| Intra-Articular Fractures | 3 | 2022 | 16 | 0.430 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2012 | 17 | 0.430 |
Why?
|
| Rotation | 5 | 2022 | 142 | 0.420 |
Why?
|
| Prostheses and Implants | 2 | 2010 | 166 | 0.410 |
Why?
|
| Radiography | 10 | 2020 | 678 | 0.400 |
Why?
|
| Bone Screws | 5 | 2023 | 181 | 0.390 |
Why?
|
| Pedicle Screws | 2 | 2023 | 17 | 0.380 |
Why?
|
| Adolescent | 4 | 2020 | 2279 | 0.380 |
Why?
|
| Arthrography | 1 | 2010 | 26 | 0.370 |
Why?
|
| Osseointegration | 3 | 2007 | 76 | 0.360 |
Why?
|
| Cartilage Diseases | 2 | 2022 | 83 | 0.350 |
Why?
|
| Occipital Bone | 3 | 2016 | 13 | 0.350 |
Why?
|
| Reference Values | 3 | 2016 | 227 | 0.350 |
Why?
|
| Osteoarthritis | 4 | 2018 | 363 | 0.350 |
Why?
|
| Case-Control Studies | 2 | 2020 | 638 | 0.320 |
Why?
|
| Spinal Diseases | 2 | 2006 | 150 | 0.310 |
Why?
|
| Models, Anatomic | 5 | 2016 | 52 | 0.310 |
Why?
|
| Tarsal Bones | 4 | 2016 | 7 | 0.310 |
Why?
|
| Elbow Joint | 2 | 2021 | 131 | 0.300 |
Why?
|
| Cohort Studies | 3 | 2019 | 1939 | 0.300 |
Why?
|
| Anthropometry | 3 | 2011 | 37 | 0.280 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2017 | 81 | 0.280 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2006 | 59 | 0.280 |
Why?
|
| Allografts | 4 | 2022 | 180 | 0.280 |
Why?
|
| Bone Substitutes | 3 | 2015 | 25 | 0.270 |
Why?
|
| Rabbits | 7 | 2021 | 280 | 0.270 |
Why?
|
| Stress, Mechanical | 6 | 2021 | 166 | 0.260 |
Why?
|
| Posture | 2 | 2016 | 78 | 0.240 |
Why?
|
| Lower Extremity | 1 | 2023 | 38 | 0.220 |
Why?
|
| Four-Dimensional Computed Tomography | 1 | 2022 | 5 | 0.220 |
Why?
|
| Osteonecrosis | 1 | 2022 | 19 | 0.210 |
Why?
|
| Osteotomy | 2 | 2022 | 163 | 0.210 |
Why?
|
| Equipment Design | 3 | 2017 | 185 | 0.210 |
Why?
|
| Wrist Joint | 1 | 2022 | 61 | 0.210 |
Why?
|
| Disease Progression | 2 | 2017 | 787 | 0.200 |
Why?
|
| Retrospective Studies | 3 | 2020 | 3273 | 0.200 |
Why?
|
| Calcification, Physiologic | 2 | 2011 | 20 | 0.200 |
Why?
|
| Athletes | 1 | 2021 | 76 | 0.200 |
Why?
|
| Atlanto-Occipital Joint | 2 | 2011 | 18 | 0.190 |
Why?
|
| Posterior Cruciate Ligament Reconstruction | 1 | 2020 | 5 | 0.190 |
Why?
|
| Ankle Joint | 2 | 2011 | 39 | 0.190 |
Why?
|
| Posterior Cruciate Ligament | 1 | 2020 | 23 | 0.190 |
Why?
|
| Hip Joint | 4 | 2023 | 367 | 0.190 |
Why?
|
| Age Factors | 2 | 2015 | 843 | 0.190 |
Why?
|
| Tomography, Spiral Computed | 1 | 2020 | 26 | 0.180 |
Why?
|
| Rats | 8 | 2018 | 854 | 0.180 |
Why?
|
| Femoral Fractures | 2 | 2015 | 41 | 0.180 |
Why?
|
| Motion | 2 | 2018 | 24 | 0.180 |
Why?
|
| Pubic Bone | 1 | 2019 | 3 | 0.180 |
Why?
|
| Groin | 1 | 2019 | 4 | 0.180 |
Why?
|
| Pubic Symphysis | 1 | 2019 | 3 | 0.180 |
Why?
|
| Lordosis | 1 | 2020 | 42 | 0.180 |
Why?
|
| Laminoplasty | 1 | 2018 | 1 | 0.170 |
Why?
|
| Suture Anchors | 1 | 2019 | 71 | 0.170 |
Why?
|
| Aged, 80 and over | 5 | 2018 | 4851 | 0.170 |
Why?
|
| Dogs | 7 | 2007 | 253 | 0.170 |
Why?
|
| Software | 3 | 2019 | 72 | 0.170 |
Why?
|
| Chronic Pain | 2 | 2019 | 112 | 0.170 |
Why?
|
| Growth Differentiation Factor 6 | 1 | 2018 | 1 | 0.160 |
Why?
|
| Predictive Value of Tests | 2 | 2010 | 521 | 0.160 |
Why?
|
| Asymptomatic Diseases | 1 | 2017 | 18 | 0.160 |
Why?
|
| Algorithms | 3 | 2015 | 400 | 0.160 |
Why?
|
| Spondylolisthesis | 1 | 2018 | 51 | 0.160 |
Why?
|
| Hyperalgesia | 1 | 2018 | 46 | 0.150 |
Why?
|
| Biomarkers | 2 | 2018 | 689 | 0.150 |
Why?
|
| Athletic Injuries | 1 | 2019 | 178 | 0.150 |
Why?
|
| Salvage Therapy | 1 | 2017 | 36 | 0.150 |
Why?
|
| Radiculopathy | 1 | 2018 | 62 | 0.150 |
Why?
|
| Tibial Fractures | 2 | 2010 | 13 | 0.150 |
Why?
|
| Computer-Aided Design | 1 | 2017 | 16 | 0.150 |
Why?
|
| Sex Characteristics | 3 | 2016 | 132 | 0.150 |
Why?
|
| Bone Matrix | 2 | 2015 | 28 | 0.140 |
Why?
|
| Thoracic Vertebrae | 1 | 2017 | 111 | 0.140 |
Why?
|
| Rotator Cuff Injuries | 1 | 2019 | 280 | 0.140 |
Why?
|
| Arthroscopy | 2 | 2021 | 811 | 0.140 |
Why?
|
| Bone Development | 2 | 2015 | 32 | 0.140 |
Why?
|
| Compressive Strength | 2 | 2013 | 28 | 0.140 |
Why?
|
| Prospective Studies | 2 | 2019 | 1811 | 0.140 |
Why?
|
| Internal Fixators | 3 | 2012 | 54 | 0.140 |
Why?
|
| Biomimetic Materials | 1 | 2015 | 8 | 0.130 |
Why?
|
| Tissue Scaffolds | 1 | 2015 | 22 | 0.130 |
Why?
|
| Integrin alpha5beta1 | 1 | 2014 | 2 | 0.130 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 2014 | 10 | 0.130 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2014 | 5 | 0.130 |
Why?
|
| Organ Culture Techniques | 1 | 2014 | 31 | 0.130 |
Why?
|
| Growth Substances | 3 | 1999 | 41 | 0.130 |
Why?
|
| Neuropeptides | 3 | 1999 | 29 | 0.130 |
Why?
|
| Muscle Proteins | 3 | 1999 | 30 | 0.130 |
Why?
|
| Foot Orthoses | 1 | 2014 | 11 | 0.130 |
Why?
|
| Analysis of Variance | 3 | 2010 | 321 | 0.130 |
Why?
|
| Osteochondritis Dissecans | 1 | 2015 | 27 | 0.130 |
Why?
|
| Postoperative Complications | 3 | 2010 | 957 | 0.130 |
Why?
|
| Transplantation, Homologous | 5 | 2020 | 277 | 0.130 |
Why?
|
| Healthy Volunteers | 1 | 2014 | 46 | 0.130 |
Why?
|
| Humerus | 1 | 2015 | 98 | 0.120 |
Why?
|
| Peptides | 3 | 1999 | 95 | 0.120 |
Why?
|
| Fracture Healing | 3 | 2010 | 40 | 0.120 |
Why?
|
| Scapula | 1 | 2014 | 79 | 0.120 |
Why?
|
| Osteogenesis, Distraction | 2 | 2005 | 12 | 0.120 |
Why?
|
| Ilium | 1 | 2014 | 31 | 0.120 |
Why?
|
| Osteogenesis | 3 | 2015 | 96 | 0.120 |
Why?
|
| Gait | 2 | 2016 | 404 | 0.120 |
Why?
|
| Glenoid Cavity | 1 | 2013 | 34 | 0.110 |
Why?
|
| Disease Models, Animal | 5 | 2021 | 724 | 0.110 |
Why?
|
| Reproducibility of Results | 2 | 2016 | 788 | 0.110 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2012 | 27 | 0.110 |
Why?
|
| External Fixators | 2 | 2003 | 11 | 0.110 |
Why?
|
| Loeys-Dietz Syndrome | 1 | 2012 | 1 | 0.110 |
Why?
|
| Osteoarthritis, Spine | 1 | 2012 | 7 | 0.110 |
Why?
|
| Calcium Phosphates | 2 | 2015 | 25 | 0.110 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2012 | 9 | 0.110 |
Why?
|
| Bone Plates | 2 | 2018 | 54 | 0.110 |
Why?
|
| Computers | 2 | 2022 | 26 | 0.100 |
Why?
|
| Mechanical Phenomena | 1 | 2011 | 22 | 0.100 |
Why?
|
| Collagen | 1 | 2011 | 102 | 0.100 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2011 | 127 | 0.100 |
Why?
|
| Pregnancy | 1 | 2012 | 403 | 0.100 |
Why?
|
| Mucins | 3 | 1999 | 6 | 0.100 |
Why?
|
| Prosthesis Design | 4 | 2019 | 502 | 0.100 |
Why?
|
| Atlanto-Axial Joint | 1 | 2010 | 18 | 0.100 |
Why?
|
| Bone and Bones | 2 | 2018 | 119 | 0.100 |
Why?
|
| Recombinant Proteins | 3 | 2006 | 251 | 0.100 |
Why?
|
| Acupuncture Points | 1 | 2010 | 1 | 0.100 |
Why?
|
| Electroacupuncture | 1 | 2010 | 1 | 0.100 |
Why?
|
| Epiphyses | 2 | 2020 | 13 | 0.100 |
Why?
|
| Fracture Fixation, Internal | 1 | 2011 | 71 | 0.090 |
Why?
|
| Ultrasonography | 1 | 2012 | 226 | 0.090 |
Why?
|
| Materials Testing | 3 | 2017 | 137 | 0.090 |
Why?
|
| Sensitivity and Specificity | 2 | 2009 | 553 | 0.090 |
Why?
|
| Decompression, Surgical | 1 | 2011 | 141 | 0.090 |
Why?
|
| Biometry | 1 | 2009 | 8 | 0.090 |
Why?
|
| Body Weights and Measures | 1 | 2009 | 8 | 0.090 |
Why?
|
| Goblet Cells | 2 | 1999 | 2 | 0.090 |
Why?
|
| Diagnostic Errors | 1 | 2009 | 40 | 0.090 |
Why?
|
| Foot | 1 | 2009 | 30 | 0.090 |
Why?
|
| Models, Biological | 3 | 2014 | 343 | 0.090 |
Why?
|
| Sex Factors | 1 | 2010 | 496 | 0.090 |
Why?
|
| Risk Assessment | 1 | 2011 | 679 | 0.080 |
Why?
|
| Bone Morphogenetic Protein 7 | 5 | 2007 | 62 | 0.080 |
Why?
|
| Calcaneus | 3 | 2013 | 6 | 0.080 |
Why?
|
| Neurosurgical Procedures | 1 | 2009 | 150 | 0.080 |
Why?
|
| Talus | 3 | 2013 | 10 | 0.080 |
Why?
|
| Models, Animal | 4 | 2012 | 126 | 0.080 |
Why?
|
| Observer Variation | 2 | 2018 | 118 | 0.080 |
Why?
|
| Calcium Sulfate | 1 | 2007 | 19 | 0.080 |
Why?
|
| Prognosis | 1 | 2010 | 840 | 0.080 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2010 | 358 | 0.070 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2006 | 14 | 0.070 |
Why?
|
| Gelatin Sponge, Absorbable | 1 | 2006 | 5 | 0.070 |
Why?
|
| Drug Synergism | 1 | 2006 | 63 | 0.070 |
Why?
|
| Tissue Adhesions | 1 | 2006 | 13 | 0.070 |
Why?
|
| Thrombin | 1 | 2006 | 12 | 0.070 |
Why?
|
| Cicatrix | 1 | 2006 | 12 | 0.070 |
Why?
|
| Hemostatics | 1 | 2006 | 11 | 0.070 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2006 | 46 | 0.070 |
Why?
|
| Torsion Abnormality | 4 | 2007 | 10 | 0.070 |
Why?
|
| Drug Therapy, Combination | 1 | 2006 | 241 | 0.070 |
Why?
|
| Bone Regeneration | 2 | 2004 | 68 | 0.070 |
Why?
|
| Immunohistochemistry | 2 | 2018 | 391 | 0.070 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2014 | 863 | 0.070 |
Why?
|
| Laminectomy | 1 | 2006 | 64 | 0.070 |
Why?
|
| Rats, Nude | 2 | 2015 | 4 | 0.060 |
Why?
|
| Prosthesis Failure | 3 | 2017 | 556 | 0.060 |
Why?
|
| Fracture Fixation | 1 | 2004 | 24 | 0.060 |
Why?
|
| Equipment Failure Analysis | 2 | 2015 | 106 | 0.060 |
Why?
|
| Silicones | 1 | 2004 | 8 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 3 | 1999 | 80 | 0.060 |
Why?
|
| Skull | 1 | 2004 | 25 | 0.060 |
Why?
|
| Metatarsal Bones | 2 | 2014 | 6 | 0.060 |
Why?
|
| Bone Diseases | 1 | 2004 | 24 | 0.060 |
Why?
|
| Titanium | 1 | 2005 | 209 | 0.060 |
Why?
|
| Bone Neoplasms | 1 | 2005 | 101 | 0.060 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2003 | 4 | 0.060 |
Why?
|
| Bone Cements | 1 | 2004 | 99 | 0.060 |
Why?
|
| Pelvis | 1 | 2023 | 30 | 0.060 |
Why?
|
| Finite Element Analysis | 1 | 2023 | 44 | 0.060 |
Why?
|
| Osteoporosis | 1 | 2004 | 80 | 0.060 |
Why?
|
| Equipment Reuse | 1 | 2003 | 3 | 0.060 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2005 | 290 | 0.060 |
Why?
|
| Tendons | 1 | 2005 | 218 | 0.060 |
Why?
|
| Ultrasonic Therapy | 1 | 2002 | 20 | 0.050 |
Why?
|
| Aging | 1 | 2012 | 1593 | 0.050 |
Why?
|
| Mice | 4 | 2012 | 1607 | 0.050 |
Why?
|
| Torque | 2 | 2017 | 27 | 0.050 |
Why?
|
| Iodoacetic Acid | 1 | 2021 | 2 | 0.050 |
Why?
|
| Musculoskeletal System | 1 | 2021 | 6 | 0.050 |
Why?
|
| Cartilage | 1 | 2022 | 148 | 0.050 |
Why?
|
| Menisci, Tibial | 1 | 2003 | 172 | 0.050 |
Why?
|
| Benchmarking | 1 | 2021 | 41 | 0.050 |
Why?
|
| Knee | 1 | 2020 | 44 | 0.050 |
Why?
|
| Ketones | 1 | 2019 | 18 | 0.050 |
Why?
|
| Benzophenones | 1 | 2019 | 27 | 0.050 |
Why?
|
| Polymers | 1 | 2019 | 42 | 0.050 |
Why?
|
| Rectus Abdominis | 1 | 2019 | 5 | 0.050 |
Why?
|
| Hernia | 1 | 2019 | 7 | 0.040 |
Why?
|
| Ligaments | 1 | 2019 | 15 | 0.040 |
Why?
|
| Thigh | 1 | 2019 | 34 | 0.040 |
Why?
|
| Polyethylene Glycols | 1 | 2019 | 55 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 1999 | 108 | 0.040 |
Why?
|
| Pain | 1 | 2022 | 391 | 0.040 |
Why?
|
| Colon | 1 | 1999 | 148 | 0.040 |
Why?
|
| Heterografts | 1 | 2018 | 14 | 0.040 |
Why?
|
| Punctures | 1 | 2018 | 10 | 0.040 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2018 | 15 | 0.040 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1998 | 11 | 0.040 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2018 | 25 | 0.040 |
Why?
|
| Tissue Banks | 1 | 2018 | 8 | 0.040 |
Why?
|
| Microfilament Proteins | 1 | 2018 | 22 | 0.040 |
Why?
|
| Calcium-Binding Proteins | 1 | 2018 | 22 | 0.040 |
Why?
|
| Awards and Prizes | 1 | 2018 | 24 | 0.040 |
Why?
|
| Nerve Growth Factor | 1 | 2018 | 31 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2018 | 65 | 0.040 |
Why?
|
| Ganglia, Spinal | 1 | 2018 | 57 | 0.040 |
Why?
|
| Intestines | 1 | 1998 | 107 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2022 | 1830 | 0.040 |
Why?
|
| Phenotype | 1 | 2018 | 355 | 0.040 |
Why?
|
| Body Weight | 2 | 2012 | 133 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 2019 | 349 | 0.040 |
Why?
|
| Mice, Transgenic | 2 | 2011 | 248 | 0.040 |
Why?
|
| Japan | 1 | 2015 | 12 | 0.030 |
Why?
|
| Elasticity | 2 | 2007 | 39 | 0.030 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2019 | 379 | 0.030 |
Why?
|
| Cytokines | 1 | 2018 | 347 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2016 | 227 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2016 | 451 | 0.030 |
Why?
|
| Trefoil Factor-3 | 3 | 1999 | 3 | 0.030 |
Why?
|
| Trefoil Factor-2 | 3 | 1999 | 4 | 0.030 |
Why?
|
| Oligopeptides | 1 | 2014 | 30 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 2014 | 20 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 47 | 0.030 |
Why?
|
| Cell Count | 1 | 2014 | 99 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 959 | 0.030 |
Why?
|
| Homeostasis | 1 | 2014 | 82 | 0.030 |
Why?
|
| Isografts | 1 | 2014 | 1 | 0.030 |
Why?
|
| Hyaline Cartilage | 1 | 2013 | 15 | 0.030 |
Why?
|
| Foot Diseases | 1 | 2013 | 1 | 0.030 |
Why?
|
| Posterior Tibial Tendon Dysfunction | 1 | 2013 | 1 | 0.030 |
Why?
|
| Foot Joints | 1 | 2013 | 4 | 0.030 |
Why?
|
| Physical Examination | 1 | 2014 | 117 | 0.030 |
Why?
|
| Arthroplasty, Replacement | 1 | 2014 | 147 | 0.030 |
Why?
|
| Sampling Studies | 1 | 2012 | 28 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2012 | 55 | 0.030 |
Why?
|
| Body Height | 1 | 2012 | 33 | 0.030 |
Why?
|
| Species Specificity | 1 | 2012 | 70 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2014 | 295 | 0.030 |
Why?
|
| Time Factors | 2 | 2010 | 1616 | 0.030 |
Why?
|
| Walking | 1 | 2014 | 252 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2015 | 1442 | 0.020 |
Why?
|
| Gene Expression | 1 | 2011 | 226 | 0.020 |
Why?
|
| Knee Prosthesis | 1 | 2014 | 248 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2010 | 40 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2012 | 432 | 0.020 |
Why?
|
| Infant | 1 | 2012 | 531 | 0.020 |
Why?
|
| Random Allocation | 1 | 2010 | 146 | 0.020 |
Why?
|
| Subtalar Joint | 1 | 2009 | 2 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2012 | 642 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2012 | 604 | 0.020 |
Why?
|
| Risk Factors | 1 | 2015 | 2443 | 0.020 |
Why?
|
| Child | 1 | 2012 | 1346 | 0.020 |
Why?
|
| Injections | 1 | 2007 | 56 | 0.020 |
Why?
|
| Orthopedic Equipment | 1 | 2006 | 7 | 0.020 |
Why?
|
| Injections, Intralesional | 1 | 2006 | 28 | 0.020 |
Why?
|
| Movement | 1 | 2007 | 143 | 0.020 |
Why?
|
| Intervertebral Disc Displacement | 1 | 2007 | 118 | 0.020 |
Why?
|
| Cattle | 1 | 2006 | 217 | 0.020 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2005 | 4 | 0.020 |
Why?
|
| Ifosfamide | 1 | 2005 | 8 | 0.020 |
Why?
|
| Tensile Strength | 1 | 2005 | 29 | 0.020 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2005 | 14 | 0.020 |
Why?
|
| Doxorubicin | 1 | 2005 | 45 | 0.020 |
Why?
|
| Fourier Analysis | 1 | 2005 | 8 | 0.020 |
Why?
|
| Bony Callus | 1 | 2005 | 8 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2007 | 495 | 0.020 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2005 | 24 | 0.020 |
Why?
|
| Anisotropy | 1 | 2005 | 58 | 0.020 |
Why?
|
| Bone Marrow | 1 | 2005 | 73 | 0.020 |
Why?
|
| Cisplatin | 1 | 2005 | 91 | 0.020 |
Why?
|
| Transplantation, Autologous | 1 | 2005 | 195 | 0.020 |
Why?
|
| Orthopedic Fixation Devices | 1 | 2004 | 24 | 0.020 |
Why?
|
| Apatites | 1 | 2004 | 1 | 0.020 |
Why?
|
| Microradiography | 1 | 2004 | 4 | 0.020 |
Why?
|
| Tissue Preservation | 1 | 2004 | 6 | 0.020 |
Why?
|
| Culture Media, Serum-Free | 1 | 2003 | 7 | 0.010 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2003 | 31 | 0.010 |
Why?
|
| Swine | 1 | 2003 | 80 | 0.010 |
Why?
|
| Wound Healing | 1 | 2004 | 168 | 0.010 |
Why?
|
| Computer Graphics | 1 | 2002 | 5 | 0.010 |
Why?
|
| Quality Control | 1 | 2002 | 43 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 437 | 0.010 |
Why?
|
| Mucin-2 | 1 | 1999 | 1 | 0.010 |
Why?
|
| Mucin-3 | 1 | 1999 | 1 | 0.010 |
Why?
|
| Acetic Acid | 1 | 1999 | 2 | 0.010 |
Why?
|
| Diphtheria Toxin | 1 | 1999 | 2 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 1999 | 7 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1999 | 26 | 0.010 |
Why?
|
| Dextran Sulfate | 1 | 1999 | 11 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 1999 | 30 | 0.010 |
Why?
|
| Base Sequence | 1 | 1999 | 134 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1999 | 193 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1999 | 246 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 1999 | 323 | 0.010 |
Why?
|
| Mutagenesis | 1 | 1998 | 12 | 0.010 |
Why?
|
| Sp1 Transcription Factor | 1 | 1998 | 8 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1998 | 145 | 0.010 |
Why?
|
| Transfection | 1 | 1998 | 125 | 0.010 |
Why?
|
| Protein Binding | 1 | 1998 | 127 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 1999 | 284 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 1998 | 88 | 0.010 |
Why?
|